Purchases and Sales Made in Q4 2024 in Rhythm Pharmaceuticals, Inc. (RYTM)
This table provides information about the institutional ownership of Rhythm Pharmaceuticals, Inc. (RYTM) during Q4 2024. The information is specifically focused on institutions that hold shares of RHYTHM PHARMACEUTICALS, INC..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Feb 14, 2025
Q4 2024
|
Algert Global LLC
San Francisco, CA |
SELL
|
- |
-12.6K- 23.3% |
$592K - $850K
|
41.6K
$2.08M
|
|
|
Feb 14, 2025
Q4 2024
|
Rafferty Asset Management, LLC
New York, NY |
SELL
|
- |
-14.2K- 21.96% |
$665K - $955K
|
50.4K
$2.52M
|
|
|
Feb 14, 2025
Q4 2024
|
Aqr Capital Management LLC
Greenwich, CT |
SELL
|
- |
-17K- 51.67% |
$795K - $1.14M
|
15.9K
$794K
|
|
|
Feb 12, 2025
Q4 2024
|
Loomis Sayles & CO L P
|
SELL
|
- |
-18.1K- 2.85% |
$851K - $1.22M
|
618K
$31M
|
|
|
Feb 14, 2025
Q4 2024
|
Israel Englander
Millennium Management LLC | New York, Ny
|
SELL
|
- |
-21.7K- 58.73% |
$1.02M - $1.46M
|
15.3K
$764K
|
|
|
Jan 24, 2025
Q4 2024
|
Abrdn PLC
|
SELL
|
- |
-32.3K- 28.62% |
$1.51M - $2.17M
|
80.5K
$4.03M
|
|
|
Feb 14, 2025
Q4 2024
|
Orbimed Advisors LLC
San Diego, CA |
SELL
|
- |
-35.9K- 8.24% |
$1.68M - $2.42M
|
400K
$20M
|
|
|
Feb 14, 2025
Q4 2024
|
Jane Street Group, LLC
New York, NY |
SELL
|
- |
-50.8K- 46.5% |
$2.38M - $3.42M
|
58.4K
$2.92M
|
|
|
Jan 24, 2025
Q4 2024
|
Jgp Global Gestao De Recursos Ltda.
|
SELL
|
- |
-51K- 90.46% |
$2.39M - $3.43M
|
5.38K
$269K
|
|
|
Feb 14, 2025
Q4 2024
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
SELL
|
- |
-62.4K- 60.67% |
$2.93M - $4.2M
|
40.4K
$2.02M
|
|
|
Feb 06, 2025
Q4 2024
|
Candriam S.C.A.
|
SELL
|
- |
-63K- 15.93% |
$2.95M - $4.24M
|
332K
$16.6M
|
|
|
Jan 17, 2025
Q4 2024
|
Nisa Investment Advisors, LLC
|
SELL
|
- |
-65K- 98.06% |
$3.05M - $4.37M
|
1.29K
$64.3K
|
|
|
Feb 14, 2025
Q4 2024
|
Rock Springs Capital Management LP
Baltimore, MD |
SELL
|
- |
-65.4K- 5.32% |
$3.07M - $4.4M
|
1.16M
$58.2M
|
|
|
Feb 13, 2025
Q4 2024
|
Federated Hermes, Inc.
Pittsburgh, PA |
SELL
|
- |
-114K- 6.87% |
$5.36M - $7.69M
|
1.55M
$77.6M
|
|
|
Feb 14, 2025
Q4 2024
|
State Street Corp
Boston, MA |
SELL
|
- |
-152K- 7.64% |
$7.14M - $10.3M
|
1.84M
$92.2M
|
|
|
Feb 14, 2025
Q4 2024
|
Baker Bros. Advisors LP
New York, NY |
SELL
|
- |
-314K- 4.91% |
$14.7M - $21.1M
|
6.08M
$305M
|
|
|
Feb 14, 2025
Q4 2024
|
Frazier Life Sciences Management, L.P.
Menlo Park, CA |
SELL
|
- |
-547K- 22.64% |
$25.7M - $36.8M
|
1.87M
$93.6M
|
|
|
Feb 10, 2025
Q4 2024
|
Primecap Management CO
Pasadena, CA |
SELL
|
- |
-646K- 8.95% |
$30.3M - $43.5M
|
6.57M
$329M
|
|
|
Feb 11, 2025
Q4 2024
|
Goldman Sachs Group Inc
New York, NY |
SELL
|
- |
-2.07M- 53.29% |
$97M - $139M
|
1.81M
$90.7M
|